Outcome measures in haemophilia: A systematic review

European Journal of Haematology

Volumn 93, Issue S76, 2014, Pages 2-15

  Boehlen, Françoise ^a   Graf, Lukas ^b   Berntorp, Erik ^c  

^a University Hospital and School of Medicine   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bleeding frequency; Bone mineral density; Haemophilia; Outcomes measures; Quality of life measurement; Scores

Indexed keywords

ARTHRITIS IMPACT MEASUREMENT SCALES; BLEEDING; BONE DENSITY; BONE RADIOGRAPHY; CARTILAGE DEGENERATION; CHILDREN HEMOPHILIA OUTCOME KIDS ASSESSMENT TOOL; CLINICAL TRIAL (TOPIC); CONVERGENT VALIDITY; COST UTILITY ANALYSIS; DAILY LIFE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FOLLOW UP; FUNCTIONAL INDEPENDENCE MEASURE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH CARE COST; HEALTH CARE QUALITY; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HEMOPHILIA JOINT HEALTH SCORE; HUMAN; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PEDIATRIC HEMOPHILIA ACTIVITIES LIST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANGE OF MOTION; REFERENCE VALUE; RELIABILITY; REVIEW; SCORING SYSTEM; SHORT FORM 36; SYSTEMATIC REVIEW; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; BLOOD CLOTTING TEST; COMPLICATION; COST BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; HEMORRHAGE; PROCEDURES; TREATMENT OUTCOME;

BLOOD COAGULATION TESTS; BONE DENSITY; COST-BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICAL EXAMINATION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84902956264     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12369     Document Type: Review

References (59)

1. Gilbert MS. Prophylaxis: musculoskeletal evaluation. Semin Hematol 1993;30(3 Suppl. 2):3-6.
2. Feldman BM, Funk S, Lundin B, Doria AS, Ljung R, Blanchette V; International Prophylaxis Study Group (IPSG). Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG). Haemophilia 2008;14(Suppl. 3):162-9.
3. Hilliard P, Funk S, Zourikian N, Bergstrom BM, Bradley CS, McLimont M, Manco-Johnson M, Petrini P, van den Berg M, Feldman BM. Haemophilia joint health score reliability study. Haemophilia 2006;12:518-25.
4. Soucie JM, Wang C, Forsyth A, Funk S, Denny M, Roach KE, Boone D; Hemophilia Treatment Center Network. Range of motion measurements: reference values and a database for comparison studies. Haemophilia 2011;17:500-7.
5. Saulyte Trakymiene S, Ingerslev J, Rageliene L. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania. Haemophilia 2010;16:479-86.
6. Groen W, van der Net J, Bos K, et al. Joint health and functional ability in children with haemophilia who receive intensive replacement therapy. Haemophilia 2011;17:783-90.
7. Groen WG, Takken T, van der Net J, Helders PJ, Fischer K. Habitual physical activity in Dutch children and adolescents with haemophilia. Haemophilia 2011;17:e906-12.
8. Feldman BM, Funk S, Hilliard P, et al. The Haemophilia Joint Health Score (HJHS) international validation study. Haemophilia 2008;14(Suppl. 2):83 (Poster 12PO85).
9. Feldman BM, Funk SM, Bergstrom BM, et al. Validation of a new pediatric joint scoring system from the International Haemophilia Prophylaxis Study Group: validity of the haemophilia joint health score. Arthritis Care Res (Hoboken) 2011;63:223-30.
10. Hilliard P, Blanchette VS, Doria A, et al. The Hemophilia Joint Health Score (HJHS) correlates highly with radiographic damage. Haemophilia 2008;14(Suppl. 2):80 (Poster 12PO56).
11. Arnold WD, Hilgartner MW. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977;59:287-305.
12. Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980;149:153-9.
13. Pettersson H, Nilsson IM, Hedner U, Noréhn K, Ahlberg A. Radiologic evaluation of prophylaxis in severe haemophilia. Acta Paediatr Scand 1981;70:565-70.
14. Silva M, Luck JV Jr, Quon D, Young CR, Chin DM, Ebramzadeh E, Fong YJ. Inter- and intra-observer reliability of radiographic scores commonly used for the evaluation of haemophilic arthropathy. Haemophilia 2008;14:504-12.
15. Doria AS, Babyn PS, Lundin B, Kilcoyne RF, Miller S, Rivard GE, Moineddin R, Pettersson H; Expert MRI Working Group of the International Prophylaxis Study Group. Reliability and construct validity of the compatible MRI scoring system for evaluation of haemophilic knees and ankles of haemophilic children. Expert MRI working group of the international prophylaxis study group. Haemophilia 2006;12:503-13.
16. Lundin B, Pettersson H, Ljung R. A new magnetic resonance imaging scoring method for assessment of haemophilic arthropathy. Haemophilia 2004;10:383-9.
17. Nuss R, Kilcoyne RF, Geraghty S, Shroyer AL, Rosky JW, Mawhinney S, Wiedel J, Manco-Johnson M. MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia 2000;6:162-9.
18. Lundin B, Ljung R, Pettersson H; European Paediatric Network for Haemophilia M. MRI scores of ankle joints in children with haemophilia-comparison with clinical data. Haemophilia 2005;11:116-22.
19. Lundin B, Babyn P, Doria AS, Kilcoyne R, Ljung R, Miller S, Nuss R, Rivard GE, Pettersson H; International Prophylaxis Study Group. Compatible scales for progressive and additive MRI assessments of haemophilic arthropathy. Haemophilia 2005;11:109-15.
20. Jelbert A, Vaidya S, Fotiadis N. Imaging and staging of haemophilic arthropathy. Clin Radiol 2009;64:1119-28.
21. Fotiadis N, Ekonomou I, Haritanti A, Tsatra I, Athanassiou-Metaxa M, Dimitriadis AS. The compatible MRI scoring system for staging of haemophilic arthropathy. Haemophilia 2008;14:866-7.
22. Melchiorre D, Linari S, Innocenti M, Biscoglio I, Toigo M, Cerinic MM, Morfini M. Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score. Haemophilia 2011;17:112-7.
23. Zukotynski K, Jarrin J, Babyn PS, Carcao M, Pazmino-Canizares J, Stain AM, Doria AS. Sonography for assessment of haemophilic arthropathy in children: a systematic protocol. Haemophilia 2007;13:293-304.
24. Keshava S, Gibikote S, Mohanta A, Doria AS. Refinement of a sonographic protocol for assessment of haemophilic arthropathy. Haemophilia 2009;15:1168-71.
25. Poonnoose PM, Manigandan C, Thomas R, Shyamkumar NK, Kavitha ML, Bhattacharji S, Srivastava A. Functional Independence Score in Haemophilia: a new performance-based instrument to measure disability. Haemophilia 2005;11:598-602.
26. Poonnoose PM, Thomas R, Keshava SN, et al. Psychometric analysis of the Functional Independence Score in Haemophilia (FISH). Haemophilia 2007;13:620-6.
27. Padankatti SM, Macaden AS, Cherian SM, et al. A patient-prioritized ability assessment in haemophilia: the Canadian Occupational Performance Measure. Haemophilia 2011;17:605-11.
28. Hassan TH, Badr MA, Fattah NR, Badawy SM. Assessment of musculoskeletal function and mood in haemophilia A adolescents: a cross-sectional study. Haemophilia 2011;17:683-8.
29. van Genderen FR, van Meeteren NL, van der Bom JG, Heijnen L, de Kleijn P, van den Berg HM, Helders PJ. Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List. Haemophilia 2004;10:565-71.
30. van Genderen FR, Westers P, Heijnen L, de Kleijn P, van den Berg HM, Helders PJ, van Meeteren NL. Measuring patients' perceptions on their functional abilities: validation of the Haemophilia Activities List. Haemophilia 2006;12:36-46.
31. Brodin E, Baghaei F, Elfvinger P, Lindvall K, Sunnerhagen KS. The Swedish version of the Haemophilia Activity List. Haemophilia 2011;17:662-8.
32. Groen WG, van der Net J, Helders PJ, Fischer K. Development and preliminary testing of a Paediatric Version of the Haemophilia Activities List (pedhal). Haemophilia 2010;16:281-9.
33. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. Br Med J 2004;329:224-7.
34. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995;7:503-20.
35. Ware JE Jr, Sherbourne CD. e MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
36. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1171-8.
37. Scalone L, Mantovani LG, Mannucci PM, Gringeri A; COCIS Study Investigators. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006;12:154-62.
38. Royal S, Schramm W, Berntorp E, Giangrande P, Gringeri A, Ludlam C, Kroner B, Szucs T; European Haemophilia Economics Study Group. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002;8:44-50.
39. Arranz P, Remor E, Quintana M, et al. Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia 2004;10:376-82.
40. Rentz A, Flood E, Altisent C, Bullinger M, Klamroth R, Garrido RP, Scharrer I, Schramm W, Gorina E; Members of the HAEMO-QoL-A Steering Committee. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia 2008;14:1023-34.
41. Gringeri A, Mantovani LG, Scalone L, Mannucci PM; COCIS Study Group. Cost of care and quality of life for patients with haemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003;102:2358-63.
42. Bullinger M, von Mackensen S, Fischer K, et al. Pilot testing of the 'Haemo-QoL' quality of life questionnaire for haemophiliac children in six European countries. Haemophilia 2002;8(Suppl. 2):47-54.
43. Pollak E, Mühlan H, Von Mackensen S, Bullinger M; HAEMO-QOL GROUP. The Haemo-QoL Index: developing a short measure for health-related quality of life assessment in children and adolescents with haemophilia. Haemophilia 2006;12: 384-92.
44. von Mackensen S, Bullinger M. Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL). Haemophilia 2004;10(Suppl. 1):17-25.
45. Young NL, Bradley CS, Wakefield CD, Barnard D, Blanchette VS, McCusker PJ. How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia? Pediatr Blood Cancer 2006;47:305-11.
46. Gringeri A, von Mackensen S, Auerswald G, et al. Health status and health-related quality of life of children with haemophilia from six West European countries. Haemophilia 2004;10(Suppl. 1):26-33.
47. Ludlam CA, Lee RJ, Prescott RJ, Andrews J, Kirke E, Thomas AE, Chalmers E, Lowe GD. Haemophilia care in central Scotland 1980-94. I. Demographic characteristics, hospital admissions and causes of death. Haemophilia 2000;6:494-503.
48. Plug I, Van Der Bom JG, Peters M, Mauser-Bunschoten EP, De Goede-Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR. Mortality and causes of death in patients with haemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006;4:510-6.
49. Tagliaferri A, Rivolta GF, Iorio A, et al. Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia 2010;16:437-46.
50. Fischer K, van der Bom JG, Molho P, Negrier C, Mauser-Bunschoten EP, Roosendaal G, De Kleijn P, Grobbee DE, van den Berg HM. Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome. Haemophilia 2002;8:745-52.
51. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe haemophilia. N Engl J Med 2007;357:535-44.
52. Ballal RD, Botteman MF, Foley I, Stephens JM, Wilke CT, Joshi AV. Economic evaluation of major knee surgery with recombinant activated factor VII in haemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling. Curr Med Res Opin 2008;24:753-68.
53. Schild FJ, Mauser-Bunschoten EP, Verbout AJ, Van Rinsum AC, Roosendaal G. Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures. J Thromb Haemost 2009;7:1741-3.
54. Tlacuilo-Parra A, Morales-Zambrano R, Tostado-Rabago N, Esparza-Flores MA, Lopez-Guido B, Orozco-Alcala J. Inactivity is a risk factor for low bone mineral density among haemophilic children. Br J Haematol 2008;140:562-7.
55. Ranta S, Viljakainen H, Makipernaa A, Mäkitie O. Hypercalciuria in children with haemophilia suggests primary skeletal pathology. Br J Haematol 2011;153:364-71.
56. Khawaji M, Astermark J, Von Mackensen S, Akesson K, Berntorp E. Bone density and health-related quality of life in adult patients with severe haemophilia. Haemophilia 2011;17:304-11.
57. Khawaji M, Akesson K, Berntorp E. Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density. Haemophilia 2009;15:261-6.
58. Christoforidis A, Economou M, Papadopoulou E, Kazantzidou E, Farmaki E, Tzimouli V, Tsatra I, Gompakis N, Athanassiou-Metaxa M. Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia. Haemophilia 2011;17:e217-22.
59. Gerstner G, Damiano ML, Tom A, Worman C, Schultz W, Recht M, Stopeck AT. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia 2009;15:559-65.